Form 4: Edwards Lifesciences Director Paul A. Laviolette Reports Acquisition of Restricted Stock Units

Director Paul A. Laviolette reports acquisition of 3,528 restricted stock units in Edwards Lifesciences Corp.

Summary

• On May 9, 2025, Paul A. Laviolette, a director of Edwards Lifesciences Corp, acquired 3,528 shares of common stock in the form of restricted stock units.
• The restricted stock units were granted under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program.
• These units are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
• Following the transaction, Laviolette directly owns 14,301 shares of Edwards Lifesciences Corp common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.

Positives

• The acquisition of restricted stock units aligns the director's interests with those of the shareholders.

Future Outlook

The restricted stock units are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency regarding the holdings of company directors.

Stakeholder Impact

• The acquisition of restricted stock units by a director can positively influence shareholder confidence.

Key Dates

Keywords

Edwards Lifesciences, Director, Stock Incentive Program, Restricted Stock Units, Beneficial Ownership, Form 4, LAVIOLETTE PAUL A